Analysis of epothilone B-induced cell death in normal ovarian cells

Cell Biology International

Volumn 37, Issue 12, 2013, Pages 1330-1339

  Rogalska, Aneta ^a   Gajek, Arkadiusz ^a   Marczak, Agnieszka ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Caspases; Epothilone B; Paclitaxel; PARP

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; EPOTHILONE B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN P53; ANTINEOPLASTIC AGENT; EPOTHILONE DERIVATIVE;

ANALYSIS OF VARIANCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL SUSPENSION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; INTEGRATION; MORPHOLOGY; MOUSE; NONHUMAN; OVARY CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CLEAVAGE; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; FEMALE; METABOLISM; OVARY; TIME; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE; EPOTHILONES; FEMALE; MICE; MICROSCOPY, FLUORESCENCE; OVARY; PACLITAXEL; POLY(ADP-RIBOSE) POLYMERASES; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84888434222     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10165     Document Type: Article

References (37)

1. Ajani JA, Blaauw AA, Spitzer G, Baker FL, Tomasovic B, Umbach G, Thielvoldt D, Zander AR, Dicke KA (1985) Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro. Exp Hematol 13 (Suppl 16): 95-100.
2. Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, Weill B, Goldwasser F (2006) Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119: 41-8.
3. Bocci G, Nicolaou KC, Kerbel RS (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 62: 6938-43.
4. Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55: 2325-33.
5. Boronkai A, Bellyei S, Szigeti A, Pozsgai E, Bognar Z, Sumegi B, Gallyas F Jr (2009) Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells. Eur J Cell Biol 88: 753-63.
6. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB (1987a) Evaluation of a tetrazolium-based semiautomated colorimetric assay-assessment of chemosensitivity testing. Cancer Res 47: 936-42.
7. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB (1987b) Evaluation of a tetrazolium-based semiautomated colorimetric assay-assessment of radiosensitivity. Cancer Res 47: 943-6.
8. Carrara L, Guzzo F, Roque DM, Bellone S, Emiliano C, Sartori E, Pecorelli S, Schwartz PE, Rutherford TJ, Santin AD (2012) Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression. Gynecol Oncol 125: 231-6.
9. Cortes J, Vidal M (2012) Beyond taxanes: the next generation of microtubule-targeting agents. Breast Cancer Res Treat 133: 821-30.
10. Diaz-Padilla I, Oza AM (2011) Epothilones in the treatment of ovarian cancer. Future Oncol 7: 559-68.
11. Fojo T, Menefee M (2007) Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents. Ann Oncol 18 (Suppl 5): v3-8.
12. Gasiorowski K, Brokos B, Kulma A, Ogorzalek A, Skorkowska K (2001) A comparison of the methods applied to detect apoptosis in genotoxically-damaged lymphocytes cultured in the presence of four antimutagens. Cell Mol Biol Lett 6: 141-59.
13. George J, Banik NL, Ray SK (2009) Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochem Res 34: 66-78.
14. Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV, Greber UF, Fojo T (2002) Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99: 10855-60.
15. Goodin S (2008) Novel cytotoxic agents: epothilones. Am J Health Syst Pharm 65: S10-5.
16. Hammer S, Sommer A, Fichtner I, Becker M, Rolff J, Merk J, Klar U, Hoffmann J (2010) Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer. Clin Cancer Res 16: 1452-65.
17. Hannun YA (1997) Apoptosis and the dilemma of cancer chemotherapy. Blood 89: 1845-53.
18. Hoffmann J, Vitale I, Buchmann B, Galluzzi L, Schwede W, Senovilla L, Skuballa W, Vivet S, Lichtner RB, Vicencio JM, Panaretakis T, Siemeister G, Lage H, Nanty L, Hammer S, Mittelstaedt K, Winsel VS, Eschenbrenner J, Castedo M, Demarche C, Klar U, Kroemer G (2008) Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Res 68: 5301-8.
19. Ioffe ML, White E, Nelson DA, Dvorzhinski D, DiPaola RS (2004) Epothilone induced cytotoxicity is dependent on p53 status in prostate cells. Prostate 61: 243-7.
20. Jelinek M, Balu Ikova K, Kopperova D, McOvá-Fürstová V, Ramek J, Fidlerova J, Zanardi I, Ojima I, Ková J (2013) Caspase-2 is involved in cell death induction by taxanes in breast cancer cells. Cancer Cell Int 13: 42.
21. Kaiser S, Muller JJ, Froehlich PE, Gnoatto SC, Bergold AM (2013) From bacteria to antineoplastic: epothilones a successful history. Anticancer Agents Med Chem 13: 1057-68.
22. Kleffel S, Schatton T (2013) Tumor dormancy and cancer stem cells: two sides of the same coin? Adv Exp Med Biol 734: 145-79.
23. Lee FY, Smykla R, Johnston K, Menard K, McGlinchey K, Peterson RW, Wiebesiek A, Vite G, Fairchild CR, Kramer R (2009) Preclinical efficacy spectrum and pharmacokinetics of ixabepilone. Cancer Chemother Pharmacol 63: 201-12.
24. Long X, Li Y, Qi Y, Xu J, Wang Z, Zhang X, Zhang D, Zhang L, Huang J (2012) XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells. FASEB J 27: 1062-73.
25. Mozzetti S, Martinelli E, Raspaglio G, Prislei S, De Donato M, Filippetti F, Shahabi S, Scambia G, Ferlini C (2012) Gli family transcription factors are drivers of patupilone resistance in ovarian cancer. Biochem Pharmacol 84: 1409-18.
26. Park CH, Amare M, Savin MA, Goodwin JW, Newcomb MM, Hoogstraten B (1980) Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood 55: 595-601.
27. Pasquier J, Magal P, Boulange-Lecomte C, Webb G, Le Foll F (2011) Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model. Biol Direct 6: 5.
28. Quick QA (2008) Epothilone B induces glioblastoma cell death via survivin down-regulation. Exp Oncol 30: 195-201.
29. Rogalska A, Marczak A, Gajek A, Szwed M, Sliwinska A, Drzewoski J, Jóźwiak Z (2013) Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B. Toxicol In Vitro 27: 239-49.
30. Shahabi S, Yang CP, Goldberg GL, Horwitz SB (2010) Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells. Gynecol Oncol 119: 345-50.
31. Sundman-Engberg B, Tidefelt U, Paul C (1998) Toxicity of cytostatic drugs to normal bone marrow cells in vitro. Cancer Chemother Pharmacol 42: 17-23.
32. Szmyd RS, Goralcyk AG, Skalniak L, Cierniak A, Lipert B, Larese Filon FL, Crosera M, Borowczyk J, Laczna E, Drukala J, Klein A, Jura J (2012) Effect of silver nanoparticles on human primary keratinocytes. Biol Chem 394: 113-23.
33. Taghian AG, Abi-Raad R, Assaad SI, Casty A, Ancukiewicz M, Yeh E, Molokhia P, Attia K, Sullivan T, Kuter I, Boucher Y, Powell SN (2005) Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications. J Clin Oncol 23: 1951-61.
34. Vishnu P, Colon-Otero G, Kennedy GT, Marlow LA, Kennedy WP, Wu KJ, Santoso JT, Copland JA (2012) RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. Gynecol Oncol 124: 589-97.
35. Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10: 145-7.
36. Winsel S, Sommer A, Eschenbrenner J, Mittelstaedt K, Klar U, Hammer S, Hoffmann J (2011) Molecular mode of action and role of TP53 in the sensitivity to the novel epothilone sagopilone (ZK-EPO) in A549 non-small cell lung cancer cells. PLoS ONE 6: e19273.
37. Wu KD, Cho YS, Katz J, Ponomarev V, Chen-Kiang S, Danishefsky SJ, Moore MA (2005) Investigation of antitumor effects of synthetic epothilone analogs in humanmyeloma models in vitro and in vivo. Proc Natl Acad Sci USA 102: 10640-5.